Host response to tissue engineered devices

Advanced Drug Delivery Reviews

Volumn 33, Issue 1-2, 1998, Pages 111-139

  Babensee, Julia E ^a   Anderson, James M ^b   McIntire, Larry V ^a   Mikos, Antonios G ^a  

^a RICE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Biocompatibility; Biomaterials; Cell transplantation; Immune response; Immunoisolation; Inflammatory response

Indexed keywords

BIOCOMPATIBILITY; BONE; CELLS; IMMUNOLOGY; SKIN; TISSUE; TRANSPLANTATION (SURGICAL);

CELL TRANSPLANTATION; IMMUNOISOLATION; TISSUE ENGINEERING;

BIOMATERIALS;

BIOMATERIAL; POLYMER;

BIOCOMPATIBILITY; CELL TRANSFORMATION; DEVICE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REACTION; TISSUE TRANSPLANTATION;

EID: 0032479778     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00023-4     Document Type: Review

References (249)

1. [1] J.M. Anderson, Biocompatibility of tissue-engineered implants, in: C.W. Patrick, A.G. Mikos, L.V. McIntire (Eds.), Frontiers in Tissue Engineering, Elsevier Science Inc., Oxford, UK, (1998) pp. 152-165.
2. [2] R. Langer, J.P. Vacanti, Tissue engineering, Science 260 (1993) 920-926.
3. [3] J.A. Hubbell, Biomaterials in tissue engineering, Bio/Technology 13 (1995) 565-576.
4. [4] N.A. Peppas, R. Langer, New challenges in biomaterials, Science 263 (1994) 1715-1720.
5. [5] J.L. West, J.A. Hubbell, Bioactive polymers, in: A. Atala, D. Mooney, R. Langer, J.P. Vacanti (Eds.), Synthetic Biodegradable Polymer Scaffolds, Birkhauser, Boston, MA, 1997, pp. 83-95.
6. [6] C.K. Colton, E.S. Avgoustiniatos, Bioengineering in development of the hybrid artificial pancreas, Trans. ASME 113 (1991) 152-170.
7. [7] T. Maki, C.S. Ubhi, H. Sanchez-Farpon, S.J. Sullivan, K. Borland, T.E. Muller, B.A. Solomon, W.L. Chick, A.P. Monaco, Successful treatment of diabetes with the biohybrid pancreas in dogs, Transplantation 51 (1991) 43-51.
8. [8] T. Maki, J.P.A. Lodge, M. Carretta, H. Ohzato, K.M. Borland, S.J. Sullivan, J. Staruk, T.E. Muller, B.A. Solomon, W.L. Chick, A.P. Monaco, Treatment of severe diabetes mellitus for more than one year using a vascularized hybrid artificial pancreas, Transplantation 55 (1993) 713-718.
9. [9] W.S. Arnaout, A.D. Moscioni, R.L. Barbour, A.A. Demetriou, Development of bioartificial liver: bilirubin conjugation in Gunn rats, J. Surg. Res. 48 (1990) 379-382.
10. [10] S.L. Nyberg, K. Shirabe, M.V. Peshwa, T.D. Sielaff, P.L. Crotty, H.J. Mann, R.P. Remmel, W.D. Payne, W.-S. Hu, F.B. Cerra, Extracorpeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions, Cell Transplant. 2 (1993) 441-452.
11. [11] D.A. Barrera, E. Zylastra, P.T. Lansbury Jr, R. Langer, Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine), J. Am. Chem. Soc. 115 (1993) 11010-11011.
12. [12] A.D. Cook, J.S. Hrkach, N.N. Gao, I.M. Johnson, U.B. Pajvani, S.M. Cannizzaro, R. Langer, Characterization and development of RGD-peptide-modified poly(lactic acid-colysine) as an interactive, resorbable biomaterial, J. Biomed. Mater. Res. 35 (1997) 513-523.
13. [13] P.J.A. in't Veld, Z-R. Shen, G.A.J. Takens, P.J. Dijkstra, J. Feijen, Glycine/glycolic acid based copolymers, J. Polym. Sci.: Polym. Chem. 32 (1994) 1063-1069.
14. [14] H.A. Clayton, R.F.L. James, N.J.M. London, Islet microencapsulation: a review, Acta Diabetol. 30 (1993) 181-189.
15. [15] S.R. Winn, P.A. Tresco, B. Zielinski, L.A. Greene, C.B. Jaeger, P. Aebischer, Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells, Exp. Neurol. 113 (1991) 322-329.
16. [16] P. Aebischer, P.A. Tresco, J. Sagen, S.R. Winn, Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats, Brain Res. 560 (1991) 43-49.
17. [17] S. Bruni, T.M.S. Chang, Hepatocytes immobilized by microencapsulation in artificial cells: effects on hyperbilirubimeia in Gunn rats, Biomater. Artif. Cells, Artif. Organs 17 (1989) 403-411.
18. [18] Z. Cai, Z. Shi, M. Sherman, A.M. Sun, Development and evaluation of a system of microencapsulation of primary rat hepatocytes, Hepatology 10 (1989) 855-860.
19. [19] V. Dixit, G. Gitnick, Transplantation of microencapsulated heptocytes for liver function replacement, J. Biomater. Sci. Polym. Edn. 7 (1995) 343-357.
20. [20] X.W. Fu, A.M. Sun, Microencapsulated parathyroid cells as a bioartificial parathyroid, Transplantation 47 (1989) 432-435.
21. [21] C. Hasse, J. Schrezenmeir, B. Stinner, C. Schark, P.K. Wagner, K. Neumann, M. Rothmund, Successful allotransplantation of microencapsulated parathyroid in rats, World J. Surg. 18 (1994) 630-634.
22. [22] H-W. Liu, F.A. Ofosu, P.L. Chang, Expression of human factor IX by microencapsulated recombinant fibroblasts, Hum. Gene Ther. 4 (1993) 291-301.
23. [23] A. Al-Hendy, G. Hortelano, G.S. Tannenbaum, P.L. Chang, Correction of the growth defect in dwarf mice with nonautologous microencapsulated myoblasts - An alternate approach to somatic gene therapy, Hum. Gene Ther. 6 (1995) 165-175.
24. [24] I.T. Tai, A.M. Sun, Microencapsulation of recombinant cells: a new delivery system for gene therapy, FASEB J. 7 (1993) 1061-1069.
25. [25] M. Hughes, A. Vassilakos, D.W. Andrews, G. Hortelano, J.W. Belmont, P.L. Chang, Delivery of a secretable adenosine deaminase through microcapsules - A novel approach to somatic gene therapy, Hum. Gene Ther. 5 (1994) 1445-1455.
26. [26] H.F.J. Savelkoul, R. Van Ommen, A.C.T.M. Vossen, E.G. Breedland, R.L. Coffman, A. van Oudenaren, Modulation of systemic cytokine levels by implantation of alginate encapsulated cells, J. Immunol. Methods 170 (1994) 185-196.
27. [27] C.A. Crooks, J.A. Douglas, R.L. Broughton, M.V. Sefton, Microencapsulation of mammalian cells in a HEMA-MMA copolymer: effects on capsule morphology and permeability, J. Biomed. Mater. Res. 24 (1990) 1241-1262.
28. [28] H. Uludag, V. Horvath, J.P. Blask, M.V. Sefton, Viability and protein secretion from human hepatoma (HepG2) cells encapsulated in 400 μm polyacrylate microcapsules by submerged nozzle-liquid jet extrusion, Biotechnol. Bioeng. 44 (1994) 1199-1204.
29. [29] M.V. Sefton, L. Kharlip, Insulin release from rat pancreatic islets microencapsulated in a HEMA-MMA polyacrylate, in: R.P. Lanza, W.L. Chick (Eds.), Pancreatic Islet Transplantation, Vol. III: Immunoisolation of Pancreatic Islets, R.G. Landes Company, Austin, TX, 1994, pp. 107-117.
30. [30] C.D.M. Wells, M.M. Fisher, M.V. Sefton, Microencapsulation of viable hepatocytes in HEMA-MMA microcapsules: a preliminary study, Biomaterials 14 (1993) 615-620.
31. [31] T. Roberts, U. De Boni, M.V. Sefton, Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate-methyl methacrylate copolymer, Biomaterials 17 (1996) 267-276.
32. [32] H. Uludag, M.V. Sefton, Microencapsulated human hepatoma cells: in vitro growth and protein release, J. Biomed. Mater. Res. 27 (1993) 1213-1224.
33. [33] J.E. Babensee, U. De Boni, M.V. Sefton, Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel, J. Biomed. Mater. Res. 26 (1992) 1401-1418.
34. [34] M. Tse, H. Uludag, M.V. Sefton, P.L. Chang, Secretion of recombinant proteins from hydroxyethyl methacrylate-methyl methacrylate capsules, Biotechnol. Bioeng. 51 (1996) 271-280.
35. [35] P.E. Lacy, O.D. Hegre, A. Gerasimidi-Vazeou, F.T. Gentile, K.E. Dionne, Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets, Science 254 (1991) 1782-1784.
36. [36] R.P. Lanza, K.M. Borland, J.E. Staruk, M.C. Appel, B.A. Solomon, W.L. Chick, Transplantation of encapsulated canine islets into spontaneously diabetic BB/Wor rats without immunosuppression, Endocrinology 131 (1992) 637-642.
37. [37] R.P. Lanza, P. Lodge, K.M. Borland, M. Carretta, S.J. Sullivan, A.M. Beyer, T.E. Muller, B.A. Solomon, T. Maki, A.P. Monaco, W.L. Chick, Transplantation of islets allografts using a diffusion-based biohybrid artificial pancreas: long-term studies in diabetic pancreatectomized dogs, Transplant. Proc. 25(1) (1993) 978-980.
38. [38] P. Aebischer, M. Goddard, A.P. Signore, R.L. Timpson, Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells, Exp. Neurol. 126 (1994) 151-158.
39. [39] J.H. Kordower, Y-T. Liu, S. Winn, D.F. Emerich, Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral neuroanatomical, and neurochemical analysis, Cell Transplant. 4(2) (1995) 155-171.
40. [40] D.F. Emerich, P.E. McDermott, P.M. Krueger, S.R. Winn, Intrastriatal implants of polymer-encapsulated PC12 cells: effect on motor function in aged rats, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 18 (1994) 935-946.
41. [41] D. Hoffman, X.O. Breakefield, M.P. Short, P. Aebischer, Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF, Exp. Neurol. 122 (1993) 100-106.
42. [42] S.R. Winn, J.P. Hammang, D.F. Emerich, A. Lee, R.D. Palmiter, E.E. Baetge, Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons, Proc. Natl. Acad. Sci. USA 91 (1994) 2324-2328.
43. [43] D.F. Emerich, S.R. Winn, J. Harper, J.P. Hammang, E.E. Baetge, J.H. Kordower, Implants of polymer-encapsulated human NGF-secreting cells in the non-human primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons, J. Comp. Neurol. 349 (1994) 148-164.
44. [44] J.H. Kordower, S.R. Winn, Y-T. Liu, E.J. Mufson, J.R. Sladek, J.P. Hammang, E.E. Baetge, D.E. Emerich, The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor, Proc. Natl. Acad. Sci. USA 91 (1994) 10898-10902.
45. [45] D.F. Emerich, J.P. Hammang, E.E. Baetge, S.R. Winn, Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum, Exp. Neurol. 130 (1994) 141-150.
46. [46] J.P. Hammang, D.F. Emerich, S.R. Winn, A. Lee, M.D. Lindner, F.T. Gentile, E.J. Doherty, J.H. Kordower, E.E. Baetge, Delivery of neurotrophic factors to the CNS using encapsulated cells: developing treatments for neurodegenerative diseases, Cell Transplant. 4 (1995) S27-S28.
47. [47] M.D. Lindner, S.R. Winn, E.E. Baetge, J.P. Hammang, F.T. Gentile, E. Doherty, P.E. McDermott, B. Frydel, D. Ullman, T. Schallert, D.F. Emerich, Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and Parkinsonian symptoms, Exp. Neurol. 132 (1995) 62-76.
48. [48] J. Sagan, Chrommaffin cell transplants for alleviation of chronic pain, ASAIO J. 38 (1992) 24-28.
49. [49] J.M. Joseph, M.B. Goddard, J. Mills, V. Padrun, A. Zurn, B. Zielinski, J. Favre, J.P. Gardaz, F. Mosimann, J. Sagan, L. Christenson, P. Aebischer, Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain, Cell Transplant. 3 (1994) 355-364.
50. [50] J.H. Brauker, V.E. Carr-Brendel, L.A. Martinson, J. Crudele, W.D. Johnston, R.C. Johnson, Neovascularization of synthetic membranes directed by membrane microarchitecture, J. Biomed. Mater. Res. 29 (1995) 1517-1524.
51. [51] J. Brauker, L.A. Martinson, R.S. Hill, S.K. Young, V.E. Carr-Brendel, R.C. Johnson, Neovascularization of immunoisolation membranes: the effect of membrane architecture and encapsulated tissue, Cell Transplant. 1(2-3) (1992) 163.
52. [52] R.S. Hill, S.K. Young, L.A. Martinson, R.W. Dudek, Macroporous devices for diabetes correction, in: R.P. Lanza, W.L. Chick (Eds.), Pancreatic Islet Transplantation, Vol. III: Immunoisolation of Pancreatic Islets, Landes Company, Austin, TX, 1994, pp. 147-155.
53. [53] V.E. Carr-Brendel, R.L. Geller, T.J. Thomas, D.R. Boggs, S.K. Young, J. Crudele, L.A. Martinson, D.A. Maryanov, R.C. Johnson, J.H. Brauker, Transplantation of cells in an immunoisolation device for gene therapy, Methods Mol. Biol. 63 (1997) 373-387.
54. [54] J.M. Pachence, Collagen-based devices for soft tissue repair, J. Biomed. Mater. Res. 33 (1996) 35-40.
55. [55] S. Nehrer, H.A. Breinan, A. Ramappa, G. Young, S. Shortkroff, L.K. Louie, C.B. Sledge, I.V. Yannas, M. Spector, Matrix collagen type and pore size influence behavior of seeded canine chondrocytes, Biomaterials 18 (1997) 769-776.
56. [56] H. Shibata, N. Shioya, Y. Kuroyanagi, Development of new wound dressing composed of spongy collagen sheet containing dibutyryl cyclic AMP, J. Biomater. Sci., Polym. Edn. 8 (1997) 601-621.
57. [57] M.J.A. van Luyn, J. Verheul, P.B. van Wachem, Regeneration of full-thickness wounds using collagen split grafts, J. Biomed. Mater. Res. 29 (1995) 1425-1436.
58. [58] M.H. Spilker, I.V. Yannas, H-P. Hsu, T.V. Norregaard, S.K. Kostyk, M. Spector, The effects of collagen-based implants on early healing of the adult rat spinal cord, Tissue Eng. 3 (1997) 309-317.
59. [59] D.L. Ellis, I.V. Yannas, Recent advances in tissue synthesis in vivo by use of collagen-glycosaminoglycan copolymers, Biomaterials 17 (1996) 291-299.
60. [60] L.K. Louie, I.V. Yannas, H-P. Hsu, M. Spector, Healing of tendon defects implanted with a porous collagen-GAG matrix: histological evaluation, Tissue Eng. 3 (1997) 187-195.
61. [61] X.J. Tong, K. Hirai, H. Shimada, Y. Mizutani, T. Izumi, N. Toda, P. Yu, Sciatic nerve regeneration navigated by laminin-fibronectin double coated biodegradable collagen grafts in rats, Brain Res. 663 (1994) 155-162.
62. [62] B.R. Sickel, D. Jones, K.J. Hekimian, K.K. Wong, D.P. Chakalis, P.D. Costas, Hyaluronic acid through a new injectable nerve guide delivery system enhances peripheral nerve regeneration in the rat, J. Neurosci. Res. 40 (1995) 318-324.
63. [63] D.J. Byrne, J. Hardy, R.A. Wood, R. McIntosh, A. Cushieri, Effect of fibrin glues on the mechanical properties of healing wounds, Br. J. Surg. 78 (1991) 841-843.
64. [64] A.G. Mikos, A.J. Thorsen, L.A. Czerwonka, Y. Bao, R. Langer, D.N. Winslow, J.P. Vacanti, Preparation and characterization of poly(L-lactic acid) foams, Polymer 35 (1994) 1068-1077.
65. [65] S.L. Ishaug, M.J. Yaszemski, R. Bizios, A.G. Mikos, Osteoblast function on synthetic biodegradable polymers, J. Biomed. Mater. Res. 28 (1994) 1445-1453.
66. [66] L.E. Freed, J.C. Marquis, A. Nohria, J. Emmanual, A.G. Mikos, R. Langer, Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers, J. Biomed. Mater. Res. 27 (1993) 11-23.
67. [67] L.E. Freed, D.A. Grande, Z. Lingbin, J. Emmanual, J.C. Marquis, R. Langer, Joint resurfacing using allograft chondrocytes and synthetic biodegradable polymer scaffolds, J. Biomed. Mater. Res. 28 (1994) 891-899.
68. [68] D.S. Grande, S.S. Southerland, R. Manji, D.W. Pate, R.E. Schwartz, P.A. Lucas, Repair of articular cartilage defects using mesenchymal stem cells, Tissue Eng. 1 (1995) 345-353.
69. [69] Y. Cao, J.P. Vacanti, X. Ma, K.T. Paige, J. Upton, Z. Chowanski, B. Schloo, R. Langer, C.A. Vacanti, Generation of neo-tendon using synthetic polymers seeded with tenocytes, Transplant. Proc. 26 (1994) 3390-3392.
70. [70] A. Atala, J.P. Vacanti, C.A. Peters, J. Mandell, A.B. Retik, M.R. Freeman, Formation of urothelial structure in vivo from disassociated cells attached to biodegradable polymer scaffolds in vitro, J. Urol. 148 (1992) 658-662.
71. [71] G.M. Organ, D.J. Mooney, L.K. Hansen, B. Schloo, J.P. Vacanti, Enterocyte transplantation using cell-polymer devices to create intestinal epithelial-lined tubes, Transplant. Proc. 25 (1993) 998-1001.
72. [72] L.B. Johnson, J. Aiken, D. Mooney, B.L. Schloo, L. Griffith-Cima, R. Langer, J.P. Vacanti, The mesentery as a laminated vascular bed for hepatocyte transplantation, Cell Transplant. 3 (1994) 273-281.
73. [73] C.A. Vacanti, W. Kim, J. Upton, D. Mooney, J.P. Vacanti, The efficacy of periosteal cells compared to chondrocytes in the tissue engineered repair of bone defects, Tissue Eng. 1 (1995) 301-308.
74. [74] J-H. Juang, S. Bonner-Weir, Y. Ogawa, J.P. Vacanti, G.C. Weir, Outcome of subcutaneous islet transplantation improved by polymer device, Transplantation 61 (1996) 1557-1561.
75. [75] J.C. Gilbert, T. Takada, S.E. Stern, R. Langer, J.P. Vacanti, Cell Transplantation of genetically altered cells on biodegradable polymer scaffolds in syngeneic rats, Transplantation 56 (1993) 423-427.
76. [76] R.C. Thomson, M.J. Yaszemski, J.M. Powers, A.G. Mikos, Fabrication of biodegradable polymer scaffolds to engineer trabecular bone, J. Biomater. Sci., Polym. Edn. 7 (1995) 23-38.
77. [77] S.L. Ishaug-Riley, G.M. Crane, A. Gurlek, M.J. Miller, A.W. Yasko, M.J. Yaszemski, A.G. Mikos, Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery, J. Biomed. Mater. Res. 36 (1997) 1-8.
78. [78] S.L. Ishaug, G.M. Crane, M.J. Miller, A.W. Yasko, M.J. Yaszemski, A.G. Mikos, Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds, J. Biomed. Mater. Res. 36 (1997) 17-28.
79. [79] C.A. Vacanti, R. Langer, B. Schloo, J.P. Vacanti, Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation, Plast. Reconstr. Surg. 88 (1991) 753-759.
80. [80] D.J. Mooney, G. Organ, J.P. Vacanti, R. Langer, Design and fabrication of biodegradable polymer devices to engineer tubular tissues, Cell Transplant. 3 (1994) 203-210.
81. [81] D.J. Mooney, S. Park, P.M. Kaufman, K. Sano, K. McNamara, J.P. Vacanti, R. Langer, Biodegradable sponges for hepatocyte transplantation, J. Biomed. Mater. Res. 29 (1995) 959-965.
82. [82] P.M. Kaufmann, S. Heimrath, B.S. Kim, D.J. Mooney, Highly porous polymer matrices as a three-dimensional culture system for hepatocytes, Cell Transplant. 6 (1997) 463-468.
83. [83] M.C. Wake, P.K. Gupta, A.G. Mikos, Fabrication of pliable biodegradable polymer foams to engineer soft tissues, Cell Transplant. 5 (1996) 465-473.
84. [84] J.H. de Groot, F.M. Zijlstra, H.W. Kuipers, A.J. Pennings, J. Klompmaker, R.P.H. Veth, H.W.B. Jansen, Meniscal tissue regeneration in porous 50/50 copoly(L-lactide/ε-caprolactone) implants, Biomaterials 18 (1997) 613-622.
85. [85] W.F.A. den Dunnen, I. Stokroos, E.H. Blaauw, A. Holwerda, A.J. Pennings, P.H. Robinson, J.M. Schakenraad, Light-microscopic and electron-microscopic evaluation of short-term nerve regeneration using a biodegradable poly(DL-lactide-ε-caprolactone) nerve guide, J. Biomed. Mater. Res. 31 (1996) 105-115.
86. [86] C.T. Laurencin, S.F. El-Amin, S.E. Ibim, D.A. Willoughby, M. Attawia, H.R. Allcock, A.A. Ambrosio, A highly porous 3-dimensional polyphosphazene polymer matrix for skeletal tissue regeneration, J. Biomed. Mater. Res. 30 (1996) 133-138.
87. [87] F. Langone, S. Lora, F.M. Veronese, P. Caliceti, P.P. Parnigotto, F. Valenti, G. Palma, Peripheral nerve repair using a poly(organo)phosphazene tubular prosthesis, Biomaterials 16 (1995) 347-353.
88. [88] M.J. Yaszemski, R.G. Payne, W.C. Hayes, R.S. Langer, T.B. Aufdemorte, A.G. Mikos, The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold, Tissue Eng. 1 (1995) 41-52.
89. [89] L.J. Suggs, R.G. Payne, J. Yaszemski, L.B. Alemany, A.G. Mikos, Synthesis and characterization of a block copolymer consisting of poly(propylene fumarate) and poly(ethylene glycol), Macromolecules 30 (1997) 4318-4323.
90. [90] G.J. Beumer, C.A. van Blitterswijk, D. Bakker, M.A. Ponec, A new biodegradable matrix as part of a cell seeded skin substitute for the treatment of deep dermal skin defects: a physico-chemical characterization, Clin. Mater. 14 (1993) 21-27.
91. [91] G.J. Beumer, C.A. van Blitterswijk, D. Bakker, M. Ponec, Cell-seeding and in vitro biocompatibility evaluation of polymeric matrices of PEO/PBT copolymers and PLLA, Biomaterials 14 (1993) 598-604.
92. [92] J.M. Anderson, Mechanisms of inflammation and infection with implanted devices, Cardiovasc. Pathol. 2 (1993) 33S-41S.
93. [93] J.M. Anderson, Inflammatory response to implants, Trans. Am. Soc., Intern. Organs 24 (1988) 101-107.
94. [94] J.M. Anderson, Perspectives on the in vivo responses of biodegradable polymers, in: J.O. Hollinger (Ed.), Biomedical Applications of Synthetic Biodegradable Polymers, CRC Press, Boca Raton, 1995, pp. 223-233.
95. [95] K.H. Lam, J.M. Schakenraad, H. Esselbrugge, J. Feijen, P. Nieuwenhuis, The effect of phagocytosis of poly(L-lactic acid) fragments on cellular morphology and viability, J. Biomed. Mater. Res. 27 (1993) 1569-1577.
96. [96] R. Nakaoka, Y. Tabata, Y. Ikada, Production of interleukin 1 from macrophages incubated with poly(DL-lactic acid) granules containing ovalbumin, Biomaterials 17 (1996) 2253-2258.
97. [97] J.M. Anderson, H. Niven, J. Pelagalli, L.S. Olanoff, R.D. Jones, The role of the fibrous capsule in the function of implanted drug-polymer sustained release systems, J. Biomed. Mater. Res. 15 (1981) 889-902.
98. [98] R.C. Wood, E.L. LeCluyse, J.A. Fix, Assessment of a model for measuring drug diffusion through implant-generated fibrous capsule membranes, Biomaterials 16 (1995) 957-959.
99. [99] J. Bodziony, Bioartificial endocrine pancreas: foreign-body reaction and effectiveness of diffusional transport of insulin and oxygen after long-term implantation of hollow fibers into rats, Res. Exp. Med. 192 (1992) 305-316.
100. [100] U. Siebers, R. Sturm, M. Renardy, H. Planck, P. Zschocke, R.G. Bretzel, T. Zekorn, K. Federlin, Morphological studies on biocompatibility of artificial membranes for immunoisolated islet transplantation, in: K. Federlin, R.G. Bretzel, B.J. Hering (Eds.), Methods in Islet Transplantation, Georg Thieme, Stuttgart, 1990, pp. 206-208.
101. [101] D.L. Salzmann, L.B. Kleinert, S.S. Berman, S.K. Williams, The effects of porosity on endothelialization of ePTFE implanted in subcutaneous and adipose tissue, J. Biomed. Mater. Res. 34 (1997) 463-476.
102. [102] P. De Vos, J-L. Hillebrands, B.J. De Haan, J.H. Strubbe, R. Van Schilfgaarde, Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets, Transplantation 63 (1997) 824-830.
103. [103] A.G. Mikos, G. Sarakinos, M.D. Lyman, D.E. Ingber, J.P. Vacanti, R. Langer, Prevascularization of porous biodegradable polymers, Biotechnol. Bioeng. 42 (1993) 716-723.
104. [104] M.C. Wake, C.W. Patrick, A.G. Mikos, Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates, Cell Transplant. 3 (1994) 339-343.
105. [105] G.J. Picha, R.F. Drake, Pillared-surface microstructure and soft-tissue implants: effect of implant site and fixation, J. Biomed. Mater. Res. 30 (1996) 305-312.
106. [106] M.C. Wake, A.G. Mikos, G. Sarakinos, J.P. Vacanti, R. Langer, Dynamics of fibrovascular tissue ingrowth in hydrogel foams, Cell Transplant. 4 (1995) 275-279.
107. [107] D.J. Mooney, C.L. Mazzoni, C. Breuer, K. McNamara, D. Hern, J.P. Vacanti, R. Langer, Stabilized polyglycolic acid fiber-based tubes for tissue engineering, Biomaterials 17 (1996) 115-124.
108. [108] M. Fontaine, B. Schloo, R. Jenkins, S. Uyama, L. Hansen, J.P. Vacanti, Human hepatocyte isolation and transplantation into an athymic rat, using prevascularized cell polymer constructs, J. Pediatr. Surg. 30 (1995) 56-60.
109. [109] O. Bostman, E. Partio, E. Hirvensalo, P. Rokkanen, Foreign-body reactions to polyglycolide screws. Observations in 24/216 malleolar fracture cases, Acta Orthop. Scand. 63 (1992) 173-176.
110. [110] O. Bostman, Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers, J. Bone Jt. Surg. Ser B 72 (1990) 592-596.
111. [111] O. Bostman, Intense granulomatous inflammatory lesions associated with absorbable internal fixation devices made of polyglycolide in ankle fractures, Clin. Orthop. 278 (1992) 193-199.
112. [112] O. Bostman, Osteolytic changes accompanying degradation of absorbable fracture fixation implants, J. Bone Jt. Surg. Ser. B 73 (1991) 679-682.
113. [113] F.R. Rozema, J.E. Bergsma, R.R.M. Bos, G. Boering, A.J. Nijenhuis, A.J. Pennings, W.C. de Bruijn, Late tissue response to bone-plates and screws of poly(L-lactide) used for fixation of zygomatic fractures, J. Mater. Sci. Mater. Med. 5 (1994) 575-581.
114. [114] M.C. Wake, P.D. Gerecht, L. Lu, A.G. Mikos, Effects of biodegradable polymer particles on rat marrow derived stromal osteoblasts in vitro, Biomaterials (in press).
115. [115] H. Winet, J.Y. Bao, Comparative bone healing near eroding polylactide-polyglycolide implants of differing crystallinity in rabbit tibial bone chambers, J. Biomater. Sci., Polym. Edn. 8 (1997) 517-532.
116. [116] C. Martin, H. Winet, J.Y. Bao, Acidity near eroding polylactide-polyglycolide in vitro and in vivo in rabbit tibial bone chambers, Biomaterials 17 (1996) 2373-2380.
117. [117] K.H. Lam, J.M. Schakenraad, H. Groen, H. Esselbrugge, P.J. Dijkstra, J. Feijen, P. Nieuwenhuis, The influence of surface morphology and wettability on the inflammatory response against poly(L-lactic acid): a semi-quantitative study with monoclonal antibodies, J. Biomed. Mater. Res. 29 (1995) 929-942.
118. [118] K.H. Lam, P. Nieuwenhuis, I. Molenaar, H. Esselbrugge, J. Feijen, P.J. Dijkstra, J.M. Schakenraad, Biodegradation of porous versus non-porous poly(L-lactic acid) films, J. Mater. Sci. Mater. Med. 5 (1994) 181-189.
119. [119] W.F.A. den Dunnen, P.H. Robinson, R. van Wessel, A.J. Pennings, M.B.M. van Leeuwen, J.M. Schakenraad, Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(DL-lactide-ε-caprolactone), J. Biomed. Mater. Res. 36 (1997) 337-346.
120. [120] S.J. Peter, S.T. Miller, G. Zhu, A.W. Yasko, A.G. Mikos, In vivo degradation of a poly(propylene fumarate)/β-tricalcium phosphate injectable composite scaffold, J. Biomed. Mater. Res. 41 (1998) 1-7.
121. [121] G.J. Beumer, C.A. van Blitterswijk, M. Ponec, Degradative behavior of polymeric matrices in (sub)dermal and muscle tissue of the rat: a quantitative study, Biomaterials 15 (1994) 551-559.
122. [122] J.F. Cavallaro, R.D. Kemp, K.H. Kraus, Collagen fabrics as biomaterials, Biotechnol. Bioeng. 43 (1994) 781-791.
123. [123] L.M. Wilkins, S.R. Watson, S.J. Prosky, S.F. Meunier, N.L. Parenteau, Development of a bilayered living skin construct for clinical applications, Biotechnol. Bioeng. 43 (1994) 747-756.
124. [124] R.B. Fraser, M.A. MacAulay, J.R. Wright, A.M. Sun, G. Rowden, Migration of macrophage-like cells within encapsulated islets of Langerhans maintained in tissue culture, Cell Transplant. 5 (1995) 529-534.
125. [125] T. Tsukui, K. Kikuchi, A. Mabuchi, T. Sudo, T. Sakamoto, G. Asano, K. Yokomuro, Production of interleukin-1 by primary cultured parenchymal liver cells (hepatocytes), Exp. Cell Res. 210 (1994) 172-176.
126. [126] M. Kan, J. Huang, P.E. Mansson, H. Yasumito, B. Carr, W.L. McKeehan, Heparin-binding growth factor 1 (acidic fibroblast growth factor): a potential biphasic and paracrine regulator of hepatocyte regeneration, Proc. Natl. Acad. Sci. USA 86 (1989) 7432-7436.
127. [127] J. Folkman, M. Klagsbrun, Angiogenic factors, Science 23 (1987) 442-447.
128. [128] V. Guenard, N. Kleitman, T.K. Morrissey, R.P. Bunge, P. Aebischer, Syngeneic Schwann cells derived from adult nerves seeded in semipermeable guidance channels enhance peripheral nerve regeneration, J. Neurosci. 12 (1992) 3310-3320.
129. [129] W.D. Holder, H.E. Gruber, W.D. Roland, A.L. Moore, C.R. Culberson, A.B. Loebsack, K.J.L. Burg, D.J. Mooney, Increased vascularization and heterogeneity of vascular structures occurring in polyglycolide matrices containing aortic endothelial cells implanted in the rat, Tissue Eng. 3 (1997) 149-160.
130. [130] H.P. Greisler, C. Gosselin, D. Ren, S.S. Kang, D.U. Kim, Biointeractive polymers and tissue engineered blood vessels, Biomaterials 17 (1996) 329-336.
131. [131] S.K. Williams, D.G. Rose, B.E. Jarrell, Microvascular endothelial cell sodding of ePTFE vascular grafts: improved patency and stability of the cellular lining, J. Biomed. Mater. Res. 28 (1994) 203-212.
132. [132] F.R. Rozema, R.R. Bos, A.J. Pennings, H.W. Jansen, Poly(L-lactide) implants in repair of defects of the orbital floor: an animal study, J. Oral Maxillofac. Surg. 48 (1990) 1305-1309.
133. [133] R.A. Yukna, HTR polymer grafts in human peridontal osseous defects. I. 6-month clinical results, J. Periodontol. 61 (1990) 633-642.
134. [134] A.H. Reddi, Bone and cartilage differentiation, Curr. Opin. Genet. Dev. 4 (1994) 737-744.
135. [135] J.O. Hollinger, K. Leong, Poly(α-hydroxy acids): carriers for bone morphogenetic proteins, Biomaterials 17 (1996) 187-194.
136. [136] A.W. Yasko, J.M. Lane, E.J. Fellinger, V. Rosen, J.M. Wozney, E.A. Wang, The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2), J. Bone Jt. Surg. Ser. A 74 (1992) 659-670.
137. [137] S.C. Lee, M. Shea, M.A. Battle, K. Kozitza, E. Ron, T. Turek, R.G. Schaub, W.C. Hayes, Healing of large segmental defects in rat femurs as aided by rhBMP-2 in PLGA matrix, J. Biomed. Mater. Res. 28 (1994) 1149-1156.
138. [138] M. Liebergall, R.G. Young, N. Ozawa, J.H. Reese, D.T. Davy, V.M. Goldberg, A.I. Caplan, The effects of cellular manipulation and TGF-β1 in a composite bone graft, in: C.T. Brighton, G.E. Friedlaender, J.M. Lane (Eds.), Bone Formation and Repair, American Academy of Orthopaedic Surgeons, Rosemont, IL, 1994.
139. [139] T.H. Kim, F. Brown, J. Upton, J.P. Vacanti, C.A. Vacanti, Enhanced induction of engineered bone with basic fibroblast growth factor, Tissue Eng. 3 (1997) 303-308.
140. [140] M.J. Miller, D.P. Goldberg, A.W. Yasko, J.C. Lemon, W.C. Satterfield, M.C. Wake, A.G. Mikos, Guided bone growth in sheep: a model for tissue-engineered bone flaps, Tissue Eng. 2 (1996) 51-59.
141. [141] I.V. Yannas, E. Lee, D.P. Orgill, E.M. Skrabut, G.F. Murphy, Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin, Proc. Natl. Acad. Sci. USA 86 (1989) 933-937.
142. [142] I.V. Yannas, Regeneration of skin and nerve by use of collagen templates, in: M.E. Collagen III (Ed.), CRC Press, Boca Raton, FL, 1988, pp. 87-115.
143. [143] M. Merle, A.L. Dellon, J.N. Campbell, P.S. Chang, Complications from silicone polymer intubulation of nerves, Microsurgery 10 (1989) 130-133.
144. [144] J. Hill-West, S.M. Chowdhury, A.S. Sawhney, C.P. Pathak, R.C. Dunn, J.A. Hubbell, Prevention of postoperative adhesions in the rat by in situ photopolymerization of bioresorbable hydrogel barriers, Obstet. Gynecol. 83 (1994) 59-64.
145. [145] J.L. Hill-West, S.M. Chowdhury, M.J. Slepian, J.A. Hubbell, Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers, Proc. Natl. Acad. Sci. USA 91 (1994) 5967-5971.
146. [146] G.D. Block, J. Locker, W.C. Bowen, B.E. Petersen, S. Katyal, S.C. Strom, T. Riley, T.A. Howard, G.K. Michalopoulos, Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF, and TGF in a chemically defined (HGM) medium, J. Cell Biol. 132 (1995) 1133-1149.
147. [147] N.L. Sussman, G.T. Gislason, C.A. Conlin, J.H. Kelly, The Hepatix extracorpeal liver assist device: initial clinical experience, Artif. Organs 18 (1994) 390-396.
148. [148] Y. Panis, J. Cardoso, D. Houssin, La therapie genique en hepatologie, Gastroenterol. Clin. Biol. 18 (1994) 262-276.
149. [149] C.B. Newgard, Perspectives in diabetes cellular engineering and gene therapy strategies for insulin replacement in diabetes, Diabetes 43 (1994) 341-350.
150. [150] T. Scott-Burden, D.A. Engler, C.L. Tock, J.J. Schwarz, S.W. Casscells, Liposomal induction of NO synthase expression in cultured vascular smooth muscle cells, Biochem. Biophys. Res. Commun. 231 (1997) 780-783.
151. [151] T. Scott-Burden, C.L. Tock, J.J. Schwarz, S.W. Casscells, D.A. Engler, Genetically engineered smooth muscle cells as linings to improve the biocompatibility of cardiovascular prostheses, Circulation 94 (1996) 235-238.
152. [152] B.D. Kahan, Immunosuppressive therapy, Curr. Opin. Immunol. 4 (1992) 553-560.
153. [153] B.M. Meiser, B. Reichart, New trends in clinical immunosuppression, Transplant. Proc. 26 (1994) 3181-3183.
154. [154] S.F. Oluwole, M-X. Jin, N.C. Chowdhury, O.A. Ohajekwe, Effectiveness of intrathymic inoculation of soluble antigens in the induction of specific unresponsiveness to rat islet allografts without transient recipient immunosuppression, Transplantation 58 (1994) 1077-1081.
155. [155] M. Coulombe, R.G. Gill, Tolerance induction to cultured islet allografts. I. Characterization of the tolerant state, Transplantation 57 (1994) 1195-1200.
156. [156] M. Coulombe, R.G. Gill, Tolerance induction to cultured islet allografts, Transplantation 57 (1994) 1201-1207.
157. [157] G.W. Byrne, K.R. McCurry, M.J. Martin, S.M. McClellan, J.L. Platt, J.S. Logan, Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage, Transplantation 63 (1997) 149-155.
158. [158] P.Y. Benhamou, E. Stein, C. Hober, M. Miyamoto, Y. Watanabe, Y. Nomura, P.C. Watt, T. Kenmochi, F.C. Brunicardi, Y. Mullen, Ultraviolet light irradiation reduces human islet immunogenicity without altering islet function, Horm. Metab. Res. 27 (1995) 113-120.
159. [159] C.M. Habibullah, Q. Ayesha, A.A. Khan, R. Naithani, S. Lahiri, Xenotransplantation of UV-B-irradiated hepatocytes, Transplantation 59 (1995) 1495-1497.
160. [160] H. Green, O. Kehinde, J. Thomas, Growth of cultured human epidermal cells into multiple epithelia suitable for grafting, Proc. Natl. Acad. Sci. USA 76 (1979) 5665-5668.
161. [161] M. Nave, Wound bed preparation: approaches to replacement of dermis, J. Burn Care Rehabil. 13 (1992) 147-153.
162. [162] I.M. Verma, N. Somia, Gene therapy - promises, problems and prospects, Nature 389 (1997) 239-242.
163. [163] G.H. Sato, Animal cell culture, in: R. Lanza, R. Langer, W. Chick (Eds.), Principles of Tissue Engineering, R.G. Landes Company, Austin, TX, 1997, pp. 101-109.
164. [164] M.L. Sabolinski, O. Alvarez, M. Aulett, G. Mulder, N.L. Parenteau, Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers, Biomaterials 17 (1996) 311-320.
165. [165] J.L. Platt, Mechanisms of tissue injury in hyperacute xenograft rejection, ASAIO J. 38 (1992) 8-16.
166. [166] L.A. Wolf, M. Coulombe, R.G. Gill, Donor antigen-presenting cell-independent rejection of islet xenografts, Transplantation 60 (1995) 1164-1170.
167. [167] A.C. Wallgren, A. Karlsson-Parra, O. Korsgren, The main infiltrating cell in xenograft rejection is a CD4 + macrophage and not a T lymphocyte, Transplantation 60 (1995) 594-601.
168. [168] J.P. Fryer, J.R. Leventhal, A.P. Dalmasso, S. Chen, P.A. Simone, J.J. Goswitz, N.L. Reinsmoen, A.J. Matas, Beyond hyperacute rejection accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets, Transplantation 59 (1995) 171-176.
169. [169] A. Dorling, K. Riesbeck, R.I. Lechler, The T-cell response to xenografts: molecular interactions and graft-specific immunosuppression, Xeno 4 (1996) 68-76.
170. [170] N.L. Thai, S.C. Wang, L.A. Valdivia, S. Celli, M.J. Reilly, A.J. Demetris, R.L. Simmons, T.E. Starzl, Cytokine messenger RNA profiles in hamster-to-rat liver xenografts, Transplant. Proc. 25 (1993) 444-445.
171. [171] C. Chandler, E. Passaro, Transplant rejection mechanisms and treatment, Arch. Surg. 128 (1993) 279-283.
172. [172] H. Auchincloss, R. Moses, D. Conti, Rejection of transgenic skin expressing a xeno-class I antigen is CD4 dependent and CD8 independent, Transplant. Proc. 22 (1990) 1-59.
173. [173] M.H. Sayegh, B. Watschinger, C.B. Carpenter, Mechanisms of T cell recognition of alloantigen. The role of peptides, Transplantation 57 (1994) 1295-1302.
174. [174] R.S. Lee, M.J. Grusby, L.H. Glimcher, H.J. Winn, H. Auchincloss, Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo, J. Exp. Med. 179 (1994) 865-872.
175. [175] B.J. Alter, F.H. Bach, Cellular basis of the proliferative response of human T cells to mouse xenoantigens, J. Exp. Med. 171 (1990) 333-338.
176. [176] K.J. Lafferty, H.S. Warren, J.A. Woolnough, D.W. Talmage, Immunological induction of T lymphocytes: role of antigen and the lymphocyte co-stimulator, Blood Cells 4 (1978) 395-406.
177. [177] R.D. Moses, H.J. Winn, H. Auchincloss, Evidence that multiple defects in cell-surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses, Transplantation 53 (1992) 203-209.
178. [178] M.J. Irwin, W.R. Heath, L.A. Sherman, Species restricted interactions between CD8 and the 3 domain of class I influence the magnitude of the xenogeneic response, J. Exp. Med. 170 (1989) 1091-1101.
179. [179] A.C. Cunningham, T.J. Butler, J.A. Kirby, Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes, Immunology 81 (1994) 268-272.
180. [180] D.J. Lenschow, Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, J.A. Bluestone, Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig, Science 257 (1992) 789-792.
181. [181] B. Murphy, H. Auchincloss, C.B. Carpenter, M.H. Sayegh, T cell recognition of xeno-MHC peptides during concordant xenograft rejection, Transplantation 61 (1996) 1133-1137.
182. [182] C.Y. Lu, T.A. Khair-el-Din, I.A. Dawidson, T.M. Butler, K.M. Brasky, M.A. Vazquez, S.C. Sicher, Xenotransplantation, FASEB J. 8 (1994) 1122-1130.
183. [183] S.L. Swain, T cell subsets and the recognition of MHC class, Immunol. Rev. 74 (1983) 129-142.
184. [184] A.K. Abbas, K.M. Murphy, A. Sher, Functional diversity of helper T lymphocytes, Nature 383 (1996) 787-793.
185. [185] C.F. Morris, C.J. Simeonovic, M-C. Fung, J.D. Wilson, A.J. Hapel, Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice, J. Immunol. 154 (1995) 2470-2482.
186. [186] P.J. O-Connell, A. Pacheco-Silva, P.W. Nickerson, R.A. Muggia, M. Bastos, V.R. Kelly, T.R. Strom, Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts, J. Immunol. 150 (1993) 1093-1104.
187. [187] S.V. McDiarmid, D.G. Farmer, J.S. Kuniyoshi, M. Robery, A. Khadavi, A. Shahed, R.W. Buster, The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation, Transplantation 58 (1994) 690-697.
188. [188] O.M. Martinez, S.M. Krams, M. Sterneck, J.C. Vianueva, D.A. Falco, L.D. Ferrel, J. Lake, J.P. Roberts, N.L. Ascher, Intragraft cytokine profile during liver allograft rejection, Transplantation 53 (1992) 449-456.
189. [189] F.H. Bach, C. Ferran, P. Hechenleitner, W. Mark, N. Koyamada, T. Miyatake, H. Winkler, A. Badrichani, D. Candinas, W.H. Hancock, Accommodation of vascularized xenografts: expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment, Nat. Med. 3 (1997) 196-204.
190. [190] C.J. Simeonovic, M.J. Townsend, J.D. Wilson, K.U.S. McKenzie, A.J. Ramsay, K.I. Matthaei, D.A. Mann, I.G. Young, Eosinophils are not required for the rejection of neovascularized fetal pig proislet xenografts in mice, J. Immunol. 158 (1997) 2490-2499.
191. [191] C. Chandler, E. Passaro, Transplant rejection mechanisms and treatment, Arch. Surg. 128 (1993) 279-283.
192. [192] H. Uludag, J.R. Hwang, M.V. Sefton, Microencapsulated human hepatoma (HepG2) cells: capsule-to-capsule variations in protein secretion and permeability, J. Control. Release 33 (1995) 273-283.
193. [193] T.R. Mosmann, R.L. Coffman, Heterogeneity of cytokine secretion patterns and functions of helper T cells, Adv. Immunol. 46 (1989) 111-147.
194. [194] A.L. DeFranco, Molecular aspects of B-lymphocyte activation, Annu. Rev. Cell Biol. 3 (1987) 143-178.
195. [195] R.G. Gill, L. Wolf, Immunobiology of cellular transplantation, Cell Transplant. 4 (1995) 361-370.
196. [196] A.K. McNally, J.M. Anderson, Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells, Am. J. Pathol. 147 (1995) 1287-1499.
197. [197] K.M. DeFife, C.R. Jenney, A.K. McNally, E. Colton, J.M. Anderson, Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression, J. Immunol. 158 (1997) 3385-3390.
198. [198] W.J. Kao, A.K. McNally, A. Hiltner, J.M. Anderson, Role for interleukin-4 in foreign-body giant cell formation on a poly(etherurethane urea) in vivo, J. Biomed. Mater. Res. 29 (1995) 1267-1275.
199. [199] A.K. McNally, K.M. DeFife, J.M. Anderson, Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity, Am. J. Pathol. 149 (1996) 975-985.
200. [200] A.K. Abbas, A.H. Lichtman, J.S. Pober, Cellular and Molecular Immunology, W.B. Saunders Company, Harcourt Brace Jovanovich, Inc., Philadelphia, PN, USA, 1991.
201. [201] N.R. Cooper, C.G. Cochrane, The biochemistry and biologic activities of the complement and contact systems, in: W.J. Williams, E. Beutler, A.J. Erslev, M.A. Lichtman (Eds.), Hematology, 3rd ed., McGraw-Hill, New York, 1983.
202. [202] V.N. Schumaker, P. Zavodszky, P.H. Poon, Activation of the first component of complement, Annu. Rev. Immunol. 5 (1987) 21-42.
203. [203] A. Taranta, E.C. Franklin, Complement fixation by antibody fragments, Science 134 (1961) 1981.
204. [204] H.R. Colten, Y.M. Ooi, P. Edelson, Synthesis and secretion of complement proteins by macrophages, Ann. NY Acad. Sci. 332 (1979) 482-490.
205. [205] W. Muller, H. Hanauske-Abel, M. Loos, Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages. Evidence for independent production of the C1 subunits, J. Immunol. 121 (1978) 1578-1582.
206. [206] K.B.M. Reid, E. Soloman, Biosynthesis of the first component of complement by human fibroblasts, Biochem. J. 167 (1977) 647-660.
207. [207] K.-D. Kroncke, J. Funda, B. Berschick, H. Kolb, V. Kolb-Bachofen, Macrophage cytotoxicity towards isolated rat islet cells: neither lysis nor its protection by nicotinamide are beta-cell specific, Diabetologia 34 (1991) 232-238.
208. [208] A.E. Huot, H. Kruszyna, R. Kruszyna, R.P. Smith, M.P. Hacker, Formation of nitric oxide hemoglobin in erythrocytes co-cultured with alveolar macrophages taken from bleomycin treated rats, Biochem. Biophys. Res. Commun. 182 (1992) 151-157.
209. [209] A. Wennmalm, G. Benthin, A.S. Peterssen, Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell hemoglobin, Br. J. Pharmacol. 106 (1992) 507-508.
210. [210] F. Wiegard, K-D. Kroncke, V. Kolb-Bachofen, Macrophage-generated nitric oxide cytotoxic factor in destruction of alginate-encapsulated islets, Transplantation 56 (1993) 1206-1212.
211. [211] S. Moncada, R.M.J. Palmer, E.A. Higgs, Nitric oxide: physiology pathophysiology, and pharmacology, Pharmacol. Rev. 43 (1991) 109.
212. [212] C. Weber, J. Ayres-Price, M. Costanzo, A. Becker, A. Stall, NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets, Transplant. Proc. 26(3) (1994) 1116-1119.
213. [213] C. Pukel, H. Baquerizo, A. Rabinovitch, Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-, tumor necrosis factor, lymphotoxin, and interleukin 1, Diabetes 37 (1988) 133-136.
214. [214] A. Rabinovitch, W. Sumoski, R.V. Rajotte, G.L. Warnock, Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture, J. Clin. Endocrinol. Metab. 71 (1990) 152-156.
215. [215] V. Ablamunits, F. Baranova, T. Mandrup-Pulsen, J. Nerup, In vitro inhibition of insulin release by blood mononuclear cells from insulin-dependent diabetic and healthy subjects: synergistic action of IL-1 and TNF, Cell Transplant. 3 (1994) 55-60.
216. [216] D.R. Cole, M. Waterfall, M. McIntyre, J.D. Baird, Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure, Diabetologia 35 (1992) 231-237.
217. [217] L. Kesslet, C. Jesser, Y. Lambard, V. Karsten, A. Belcourt, M. Pinget, P. Poindron, Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: in vivo and in vitro studies, J. Leukocyte Biol. 60 (1996) 729-736.
218. [218] L. Bergmann, K-D. Kroncke, C. Suschek, H. Kolb, V. Kolb-Bachofern, Cytotoxic action of IL-1 against pancreatic islets is mediated via nitric oxide formation and is inhibited by NG-monomethyl-L-arginine, Fed. Eur. Biochem. Soc. 299 (1992) 103-106.
219. [219] T. Zekorn, U. Siebers, R.G. Bretzel, M. Renardy, H. Planck, P. Zschocke, K. Federlin, Protection of islets of Langerhans from interleukin-1 toxicity by artificial membranes, Transplantation 50 (1990) 391-394.
220. [220] D.H. Perlmutter, H.R. Colten, S.P. Adams, L.T. May, P.B. Sehgal, R.J. Fallon, A cytokine-selective defect in interleukin-1-mediated acute phase gene expression in a subclone of the human hepatoma cell line (HepG2), J. Biol. Chem. 264 (1989) 7669-7674.
221. [221] A. Falus, H. Rokita, E. Walcz, M. Brozik, T. Hidvegis, K. Meretey, Hormonal regulation of complement biosynthesis in human cell lines - II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line, Mol. Immunol. 27 (1990) 197-201.
222. [222] D.H. Perlmutter, L.T. May, P.B. Sehgal, Interferonβ2/interleukin 6 modulates synthesis of 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells, J. Clin. Invest. 84 (1989) 138-144.
223. [223] D. Kvale, P. Brandtzaeg, Immune modulation of adhesion molecules ICAM-1 (CD 54) and LFA-3 (CD 58) in human hepatocytic cell lines, J. Hepatol. 17 (1993) 347-352.
224. [224] H. Iwata, T. Takagi, H. Amemiya, H. Shimizu, K. Yamashita, K. Koyayashi, T. Akutsu, Agarose for a bioartificial pancreas, J. Biomed. Mater. Res. 26 (1992) 967-977.
225. [225] H. Iwata, H. Amemiya, T. Matsuda, H. Takano, R. Hayashi, T. Akutsu, Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation, Diabetes 38(S1) (1989) 224-225.
226. [226] J. Brauker, L.A. Martinson, T. Loudovaris, R.S. Hill, V. Carr-Brendel, R. Hodgson, S. Young, T.E. Mandel, B. Charlton, R.C. Johnson, Immuno-isolation with large pore membranes: allografts are protected under conditions that result in destruction of xenografts, Cell Transplant. 1 (1992) 164.
227. [227] C.J. Weber, S. Zabinski, T. Koschitzky, L. Wicker, R. Rajotte, V. D'Agati, L. Peterson, J. Norton, K. Reemtsma, The role of CD4 + helper T cells in the destruction of microencapsulated islet xenografts in NOD mice, Transplantation 49 (1990) 396-404.
228. [228] C. Weber, V. D'Agati, L. Ward, M. Costanzo, R. Rajotte, K. Reemtsma, Humoral reaction to microencapsulated rat, canine, and porcine islet xenografts in spontaneously diabetic NOD mice, Transplant. Proc. 25 (1993) 462-463.
229. [229] C. Weber, J. Ayres-Price, M. Costanzo, A. Becker, A. Stall, NOD mouse peritoneal cellular response to poly-L-lysine-alginate microencapsulated rat islets, Transplant. Proc. 26 (1994) 1116-1119.
230. [230] C.J. Weber, M.K. Hagler, J.T. Chryssochoos, C.P. Larsen, T.C. Pearson, P. Jensen, J.A. Kapp, P.S. Lindsey, CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic NOD mice, Transplant. Proc. 28 (1996) 821-823.
231. [231] C.J. Weber, M.K. Hagler, J.T. Chryssochoos, J.A. Kapp, G.S. Korbutt, R.V. Rajotte, P.S. Linsley, CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice, Cell Transplant. 6 (1997) 505-508.
232. [232] C. Weber, S. Krekun, T. Koschitzky, S. Zabinski, V. D'Agati, M. Hardy, K. Reemtsma, Prolonged functional survival of rat-to-mouse islet xenografts by ultraviolet-B (UV-B) irradiation plus microencapsulation of donor cells, Transplant. Proc. 23 (1991) 764-766.
233. [233] H. Shirwan, M. Leamer, H.K. Wang, L. Makowka, D.V. Cramer, Peptides derived from α-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4 + and CD8 + T cell and B cell responses after cardiac allograft rejection, Transplantation 59 (1995) 401-410.
234. [234] J.D. Clement, S.Y. Chan, D.K. Bishop, Allogeneic Class I MHC requirement for allogen-reactive helper T-lymphocyte responses in vivo, Transplantation 62 (1996) 386-396.
235. [235] U. Siebers, T. Zekorn, A. Horcher, G. Klock, H. Frank, R.G. Bretzel, U. Zimmermann, K. Federlin, Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients, Transplant. Proc. 26 (1994) 787-788.
236. [236] T. Zekorn, H. Entenmann, A. Horcher, U. Siebers, G. Klock, U. Zimmermann, K. Federlin, R.G. Bretzel, Lymphoid activation by micro- and macroencapsulated islets during mixed lymphocyte islet culture, Acta Diabetol. 30 (1993) 238-242.
237. [237] R.P. Lanza, A.M. Beyer, W.L. Chick, Xenogeneic humoral responses to islets transplanted in biohybrid diffusion chambers, Transplantation 57 (1994) 1371-1375.
238. [238] L.A. Martinson, J.H. Brauker, T. Loudovaris, V.E. Carr-Brendel, Specific, inducible destruction of xenografts within an immuno-isolation device does not require complement, Cell Transplant. 1 (1992) 171.
239. [239] T. Loudovaris, D. Maryanov, S. Young, S. Jacobs, L. Martinson, S. Neuenfeldt, J. Brauker, R. Johnson, Correction of diabetic NOD mice implanted with rat islets in immunoisolation devices, Cell Transplant. 3 (1994) 247.
240. [240] J. Brauker, L.A. Martinson, S.K. Young, R.C. Johnson, Local inflammatory response around diffusion chambers containing xenografts, Transplantation 61 (1996) 1671-1677.
241. [241] R.P. Lanza, D.H. Butler, K.M. Borland, J.E. Staruk, D.L. Faustamn, B.A. Solomon, T.E. Muller, R.G. Rupp, T. Maki, A.P. Monaco, W.L. Chick, Xenotransplantation of canine, bovine and porcine islets in diabetic rats without immunosuppression, Proc. Natl. Acad. Sci. USA 88 (1991) 11100-11104.
242. [242] L. Martinson, R. Pauley, J. Brauker, et al., Protection of xenografts with immunoisolation membranes, Cell Transplant. 3 (1995) 249.
243. [243] T. Loudovaris, T.E. Mandel, B. Charlton, CD4 + T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8 + T cells and B cells, Transplantation 61 (1996) 1678-1684.
244. [244] H. Widner, Immunologic aspects of intracerebral CNS tissue transplantation, in: Restoration of Brain Function by Tissue Transplantation, Basic and Clinical Aspects of Neuroscience, 5, 1993, pp. 63-74.
245. [245] P. Aebischer, M. Schluep, N. Deglon, J-M. Joseph, L. Hirt, B. Heyd, M. Goddard, J.P. Hammang, A.D. Zurn, A.C. Kato, F. Regli, E.E. Baetge, Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients, Nat. Med. 2 (1996) 696-699.
246. [246] E. Buchser, M. Goddard, B. Heyd, J.M. Joseph, J. Favre, N. de Tribolet, M. Lysaght, P. Aebischer, Immunoisolated xenogeneic chrommaffin cell therapy for chronic pain. Initial clinical experience, Anesthesiology 85 (1996) 1005-1012.
247. [247] J.M. Anderson, Inflammatory response to implants, Trans. Am. Soc. Intern. Organs 34 (1998) 101-107.
248. [248] J.M. Anderson, Mechanisms of inflammation and infection with implanted devices, Cardiovasc. Pathol. 2 (1993) 33S-41S.
249. [249] M.V. Sefton, J.E. Babensee, M.H. May, Immunoisolation, in: C.W. Patrick, A.G. Mikos, L.V. McIntire (Eds.), Frontiers in Tissue Engineering, Elsevier Science Inc., Oxford, UK (1998) pp. 248-260.